[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-351378-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-351378-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","pan-cancer-landscape-of-protein-kinase-d3-an-integrative-tcga-multi-omics-analysis-of-clinical-molecular-and-immunological-roles","Pan-cancer landscape of protein kinase D3 - An integrative TCGA multi-omics analysis of clinical, molecular, and immunological roles","","Cancer remains a leading cause of mortality worldwide and a major obstacle to improving quality of life. Protein kinase D proteins, including PRKD3, are implicated in cancer development by shaping key cellular processes. While evidence links PRKD3 to tumorigenesis in specific cancers, a comprehensive pan-cancer view is lacking. This study performs integrative analyses using TCGA, GTEx, and cBioPortal multi-omics to assess PRKD3 expression, DNA copy number, mutations, methylation, clinical associations, survival, and diagnostic potential across 33 cancer types.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/pan-cancer-landscape-of-protein-kinase-d3-an-integrative-tcga-multi-omics-analysis-of-clinical-molecular-and-immunological-roles/351378/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/pan-cancer-landscape-of-protein-kinase-d3-an-integrative-tcga-multi-omics-analysis-of-clinical-molecular-and-immunological-roles/351378.png","ImageObject",300,407,{"name":42,"@type":43},"Sophia Brooks","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-05","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main goal of the integrative pan-cancer analysis?","Question",{"text":63,"@type":64},"To characterize PRKD3 across many cancer types by integrating multi-omics data and linking it to clinical features, survival, and diagnostic potential.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which datasets were used for the analysis?",{"text":68,"@type":64},"The study used multi-omics datasets from The Cancer Genome Atlas (TCGA), the Genotype-Tissue Expression (GTEx) project, and cBioPortal.",{"name":70,"@type":61,"acceptedAnswer":71},"How did the study evaluate immune relevance?",{"text":72,"@type":64},"It examined PRKD3 correlations with immune infiltration, checkpoint gene expression, and immunotherapy response-related genomic biomarkers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},351378,1790245065,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962084925636,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","OPEN ACCESS  \nCitation: Loaiza-Moss J, Leitges M (2026) Pan-cancer landscape of protein kinase D3:  \nAn integrative TCGA multi-omics analysis of clinical, molecular, and immunological roles. PLoS One 21(4): e0346173. [https://doi](https://doi). org/10.1371/journal.pone.0346173  \nEditor: Amr Ahmed El-Arabey, Al-Azhar University / King Khalid University, EGYPT Received: September 28, 2025  \nAccepted: March 12, 2026  \nPublished: April 3, 2026  \nPeer Review History: PLOS recognizes the benefits of transparency in the peer review process; therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. The editorial history of this article is available here: [https://doi.org/10.1371/journal](https://doi.org/10.1371/journal). pone.0346173  \nCopyright: © 2026 Loaiza-Moss, Leitges. This is an open access article distributed under the terms of the Creative Commons Attribution  License, which permits unrestricted use, distribution, and reproduction in any medium,  \nRESEARCH ARTICLE  \nPan-cancer landscape of protein kinase D3: An integrative TCGA multi-omics analysis of clinical, molecular, and immunological roles  \nJocshan Loaiza-Moss, Michael Leitges*  \nFaculty of Medicine, Division of Biomedical Sciences, Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada  \n* [mleitges@mun.ca](mleitges@mun.ca)  \nAbstract  \nCancer remains a leading cause of mortality worldwide and a significant barrier to improving quality of life across all populations. The protein kinase D family, including PRKD3 , has been demonstrated to play a crucial role in cancer development through its involvement in regulating key cellular processes. Although growing evidence highlights the role of PRKD3 in the tumorigenesis of certain cancers, a comprehensive pan-cancer analysis of PRKD3 remains unavailable. To address this, we performed an integrative pan-cancer analysis of PRKD3 using multi-omics datasets from The Cancer Genome Atlas, the Genotype-Tissue Expression project, and cBioPortal. We examined PRKD3 expression, copy number variation, mutation, and DNA methylation, and evaluated their associations with clinicopathological features, patient survival, and diagnostic potential across 33 cancer types. Immune relevance was further assessed through correlations with immune infiltration, checkpoint gene expression, and immunotherapy response-related genomic biomarkers. Our results revealed that PRKD3 expression was highly heterogeneous, showing significant upregulation in liver cancer, gastric cancer, and adrenocortical carcinoma, and downregulation in others. Elevated expression was consistently associated with poor prognosis and increased stromal, neutrophil, and cancer-associated fibroblast infiltration in adrenocortical carcinoma, liver cancer, and stomach cancer, whereas paradoxical associations with favorable outcomes were observed in kidney clear cell carcinoma. PRKD3 expression also correlated with immune checkpoint molecules including PD-1, PD-L1, and CTLA-4, supporting an immunosuppressive role, while context-dependent associations with TMB and MSI highlighted its potential influence on tumor immunogenicity and responsiveness to immune checkpoint blockade. Collectively, these findings identify PRKD3 as a potential context-dependent modulator of tumor biology, prognosis, and immune interactions, underscoring its potential as abiomarker of diagnostic, prognostic, and therapeutic relevance in precision oncology.  \nPLOS One | [https://doi.org/10.1371/journal.pone.0346173](https://doi.org/10.1371/journal.pone.0346173) April 3, 2026 1 / 22  \nprovided the original author and source are credited.  \nData availability statement: All datasets analyzed in this study are publicly available from The Cancer Genome Atlas (TCGA, [https://www](https://www). [cancer.gov/tcga](cancer.gov/tcga)) and cBioPortal for Cancer Genomics ([https://www.cbioportal.org/](https://www.cbioportal.org","cbCaigdwFX9gdi6b","https://ap.wps.com/l/cbCaigdwFX9gdi6b","pdf",7941219,22,"English","# Abstract\n## Introduction\n## Methods and data sources\n## Multi-omics analyses\n## Clinical associations and survival outcomes\n## Immune relevance and immunotherapy biomarkers\n## Conclusions","[{\"question\":\"What was the main goal of the integrative pan-cancer analysis?\",\"answer\":\"To characterize PRKD3 across many cancer types by integrating multi-omics data and linking it to clinical features, survival, and diagnostic potential.\"},{\"question\":\"Which datasets were used for the analysis?\",\"answer\":\"The study used multi-omics datasets from The Cancer Genome Atlas (TCGA), the Genotype-Tissue Expression (GTEx) project, and cBioPortal.\"},{\"question\":\"How did the study evaluate immune relevance?\",\"answer\":\"It examined PRKD3 correlations with immune infiltration, checkpoint gene expression, and immunotherapy response-related genomic biomarkers.\"}]","Pan-cancer landscape of protein kinase D3 - An integrative TCGA multi-omics analysis of clinical, molecular, and immunological roles | PDF",1790093908,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5dc8054807dc46e88a1d7c9734b1994.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99e07b118836efb6cb2b08d3717210c9.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/093081e4a3feab01164ce3126c4c5b7a.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3c10fb42c941417e7b4078ebe6b38669.webp",980,1268]